However, no tumor formation was observed in mice that received the Kmt2c-targeted sgRNAs (Figure 1—figure supplement 3B), indicating that unlike p53, the tumor-suppressive role of MLL3 is specific to the oncogene and contexts. This evidence concerns the gene KMT2C and neoplasm.